💻 Technology · Next Week

Samsung officially announces Galaxy Watch 8 with non-invasive blood glucose monitoring (continuous glucose tracking) at Galaxy Unpacked (London, July 22, 2026)

Miss ✦ AI-generated prediction Published on 19. July 2026 · Predicted for 22. July 2026 · Based on: Speculative

Probability

70%

Galaxy Watch 8 test firmware has leaked repeatedly, with Tom's Guide, SamMobile, and eWeek consistently confirming non-invasive glucose monitoring via enhanced BioActive optical sensors. Samsung executives positioned glucose monitoring as the top next Watch priority at the 2025 Health Forum (Android Central). The Watch 8 is traditionally unveiled alongside the Z Fold/Flip lineup – Galaxy Unpacked on July 22, 2026 in London is the expected announcement venue. This specific product feature is not covered in any open platform prediction.

Data basis for this prediction

Tom's Guide: Samsung Galaxy Watch 8 test firmware reveals new models and glucose feature (2026)
Android Central: Samsung exec teases glucose monitoring on Galaxy Watch (2026)
SamMobile: Galaxy Watches might get blood glucose monitoring sooner than we thought (2026)
eWeek: Samsung Galaxy Watch Blood Sugar Tracking — Timeline, Research & What Works Today (2026)

Verdict: Miss

Die Vorhersage ist in zwei zentralen Punkten falsch. Erstens: Samsung stellte bei Galaxy Unpacked London (22. Juli 2026) die Galaxy Watch 9 und Watch Ultra 2 vor – nicht die Galaxy Watch 8 (die bereits 2025 erschienen war). Zweitens: Echtes nicht-invasives Glukose-Monitoring (CGM) wurde nicht angekündigt. Die Watch 9 enthält stattdessen einen sogenannten 'AGEs Index' (Advanced Glycation End-products), der mit dem BioActive-Sensor Hinweise auf den Stoffwechselzustand liefert – aber keine direkte, kontinuierliche Blutzuckermessung darstellt. Samsung arbeitet laut TechRepublic und eWeek weiterhin an nicht-invasiver Glukose-Technologie für zukünftige Geräte, hatte diese aber zum Unpacked-Termin noch nicht marktreif. Quellen: PhoneArena (https://www.phonearena.com/news/everything-samsung-announced-at-galaxy-unpacked-july-2026-fold-8-flip-8-watch-9-and-more_id182052), TechRepublic (https://www.techrepublic.com/article/news-samsung-galaxy-watch9-ultra2/), eWeek (https://www.eweek.com/de/news/samsung-galaxy-watch-blood-sugar-tracking-2026-timeline/).

Related Predictions

💻 Technology ✦ AI

Palantir Technologies Inc. (NYSE: PLTR) closes above $185.00 per share on at least one trading day in November 2026 — confirmed by Nasdaq or Bloomberg by December 1, 2026

PLTR closed at $175.40 on November 4, 2026 (after-hours: $170.88, -2.58%; intraday high: $176.54; 52-week high: $212.94). Palantir clearly beat Q3-FY2026 EPS consensus: total revenue $2.313B, US Commercial revenue +148% YoY to $984M. The $185 threshold is +5.5% above the closing price or +8.3% above after-hours levels. Typical post-earnings 'sell the news' may weigh short-term, but the 52-week high of $212.94 confirms the level is reachable. NVIDIA earnings on November 18, 2026 could serve as a sector-wide catalyst. No direct Polymarket equivalent; own estimate: ~42%.

42%

Next Month · Predicted for 30. Nov 2026

💻 Technology ✦ AI

Cerebras Systems (NASDAQ: CBRS) closes below $100.00 per share on November 10, 2026 (confirmed by Nasdaq or Bloomberg by November 11, 2026)

CBRS trades at $109.18 (October 30, 2026) — already 61% below its all-time high of $279.72. The final and largest lockup expiration is scheduled for November 10, 2026: approximately 19.4 million shares are unlocked (of three tranches of 19.4M each). Prior lockup tranches have consistently weighed on the stock. Insiders have sold ~$394.6M in shares since the May 2026 IPO — zero insider purchases. A Culper Research short-seller report has triggered multiple investigations. A close below $100 requires a ~8.4% decline — plausible given the expected supply pressure on expiration day.

62%

Next Week · Predicted for 10. Nov 2026

💻 Technology ✦ AI

ARM Holdings plc (NASDAQ: ARM) beats Q2-FY2027 EPS consensus of $0.47 per share — earnings report November 4, 2026 after market close (confirmed by ARM Holdings Investor Relations or Bloomberg by November 5, 2026, 10:00 AM ET)

ARM Holdings reports Q2 FY2027 (July–September 2026) on November 4 after market close. EPS consensus: $0.47; revenue consensus ~$1.38B (Theta Research, Oct 29). ARM is the dominant CPU IP licensor for AI servers (Neoverse), smartphones (Apple A-series, Qualcomm), and edge devices — all three segments scaling strongly in 2026. ARM has beaten EPS consensus in each of the last four quarters, driven by AI infrastructure capex. No direct Polymarket contract; analogue: S&P 500 Q3 2026 beat rate ~71%. Key risks: export control escalation (UK/US vs. China), hyperscaler capex delays, or HBM4 demand plateau.

68%

Next Week · Predicted for 4. Nov 2026